# Corneal Dystrophies: Classification and Clinical Significance

## Overview

Corneal dystrophies are a group of inherited, bilateral, and usually symmetric conditions that cause slowly progressive changes in corneal transparency and shape. They are typically non-inflammatory and non-vascularized, and they manifest without systemic disease -- with a few notable exceptions, such as macular dystrophy, which can be associated with a systemic glycosaminoglycan abnormality. Most corneal dystrophies follow an autosomal dominant inheritance pattern, though autosomal recessive and X-linked forms also exist.

## IC3D Classification System

The International Committee for Classification of Corneal Dystrophies (IC3D) established a modern classification system that integrates clinical, histopathologic, and genetic data. Dystrophies are categorized by the anatomic layer they primarily affect: epithelial and subepithelial, epithelial-stromal (Bowman layer), stromal, and endothelial. Each dystrophy is also assigned an evidence level reflecting the state of genetic knowledge: Category 1 indicates a well-defined dystrophy with identified gene mutations; Category 2 denotes a mapped gene without specific mutations identified; Category 3 describes a well-defined dystrophy whose gene has not yet been mapped; and Category 4 refers to suspected or insufficiently documented entities.

## Epithelial and Subepithelial Dystrophies

### Epithelial Basement Membrane Dystrophy (EBMD / Map-Dot-Fingerprint)

Epithelial basement membrane dystrophy is the most common anterior corneal dystrophy, with a prevalence of up to 2% in the general population. While many cases are sporadic, familial forms have been linked to the TGFBI gene. The underlying pathology involves abnormal reduplication of the epithelial basement membrane into the overlying epithelium, creating intraepithelial cysts and sheets of aberrant membrane. On slit lamp examination, three characteristic patterns may be seen: "maps" (geographic, gray-white patches of thickened basement membrane), "dots" (intraepithelial pseudocysts that appear putty-gray or translucent), and "fingerprint lines" (fine, parallel, curvilinear lines). Clinically, patients may suffer from recurrent corneal erosions -- typically manifesting as pain upon awakening, tearing, and photophobia -- as well as irregular astigmatism that degrades vision. Treatment ranges from conservative measures such as lubricants and hypertonic saline (NaCl 5%) to procedural interventions including bandage contact lenses, epithelial debridement, anterior stromal micropuncture, and phototherapeutic keratectomy (PTK). EBMD must be identified preoperatively in refractive surgery candidates, as it produces unreliable topography and increases the risk of post-LASIK erosions.

### Meesmann Dystrophy

Meesmann dystrophy is an autosomal dominant condition caused by mutations in the KRT3 or KRT12 genes encoding keratin 3 and keratin 12. It presents in early childhood with innumerable tiny intraepithelial vesicles. Most patients remain asymptomatic until later in life, when mild irritation may develop. Treatment is rarely required, though PTK can be performed in symptomatic cases.

## Epithelial-Stromal (Bowman Layer) Dystrophies

### Reis-Bucklers Dystrophy (Corneal Dystrophy of Bowman Layer Type 1, CDB1)

Reis-Bucklers dystrophy is an autosomal dominant condition caused by the R124L mutation in the TGFBI gene on chromosome 5q31. It produces irregular, geographic, confluent opacities at the level of Bowman layer. Patients typically experience recurrent erosions beginning in the first decade of life, followed by progressive anterior stromal scarring. Histologically, Bowman layer is replaced by sheet-like deposits similar to granular dystrophy material, with rod-shaped bodies visible on electron microscopy. PTK is the primary treatment, though recurrence in corneal grafts is common.

### Thiel-Behnke Dystrophy (CDB2)

Thiel-Behnke dystrophy is also autosomal dominant, caused by the R555Q mutation in the TGFBI gene. While clinically similar to Reis-Bucklers, it can be distinguished by its honeycomb-shaped opacities on retro-illumination. The key histologic difference is the presence of curly fibers (rather than rod-shaped bodies) on electron microscopy. The clinical course is generally milder than that of Reis-Bucklers.

## Stromal Dystrophies

### Lattice Dystrophy (Type 1)

Lattice dystrophy type 1 is an autosomal dominant condition caused by the R124C mutation in the TGFBI gene, resulting in amyloid deposition within the corneal stroma. On slit lamp examination, refractile, branching lattice lines are visible in the anterior and mid-stroma, best appreciated on retro-illumination. Central corneal haze increases progressively with age, and recurrent erosions are common because the amyloid deposits disrupt epithelial adhesion. The pathognomonic histologic finding is apple-green birefringence under polarized light after Congo red staining, confirming the presence of amyloid. Two important variants exist: lattice type II (Meretoja syndrome), a systemic amyloidosis caused by gelsolin gene mutations and associated with facial nerve palsy and skin laxity, and lattice type III, a late-onset autosomal recessive form with characteristically thick lattice lines. Treatment includes PTK for recurrent erosions and PK or DALK for advanced disease, though recurrence in grafts within three to five years is typical.

### Granular Dystrophy (Type 1 -- Classic Groenouw Type I)

Granular dystrophy type 1 is autosomal dominant, caused by the R555W mutation in the TGFBI gene, and involves hyaline deposition in the stroma. On slit lamp examination, discrete, white, breadcrumb-like or snowflake opacities are seen in the central anterior stroma with characteristically clear intervening spaces. On histology, the deposits stain bright red with Masson trichrome. Compared with lattice dystrophy, granular dystrophy is less prone to recurrent erosions, and the visual prognosis is generally good until later decades of life.

### Granular Dystrophy Type 2 (Avellino Dystrophy)

Avellino dystrophy is caused by the R124H mutation in the TGFBI gene and is inherited in an autosomal dominant pattern. It is unique in exhibiting combined features of both granular and lattice dystrophies, with both hyaline and amyloid deposits present. An important clinical warning applies: LASIK is absolutely contraindicated in this dystrophy because it can cause severe exacerbation of deposits at the flap interface, leading to significant vision loss. Genetic testing is recommended before refractive surgery in endemic populations, particularly those of Korean or Italian descent.

### Macular Dystrophy (Groenouw Type II)

Macular dystrophy stands apart from the other classic stromal dystrophies in several key ways. It follows autosomal recessive inheritance, caused by mutations in the CHST6 gene (encoding carbohydrate sulfotransferase 6), and involves accumulation of glycosaminoglycans (specifically keratan sulfate). On slit lamp examination, focal, gray-white, poorly defined opacities extend all the way to the limbus with diffuse stromal haze between the opacities -- unlike lattice and granular dystrophies, which spare the peripheral cornea. Paradoxically, the corneal stroma is thinner than normal rather than thicker. The deposits stain with Alcian blue and colloidal iron. Macular dystrophy is the most severe of the classic stromal triad, causing the earliest visual loss. Two subtypes are recognized based on serum keratan sulfate levels: Type I (no detectable serum keratan sulfate) and Type II (normal serum levels). Treatment typically requires PK or DALK, and among the stromal dystrophies, macular dystrophy has the lowest recurrence rate in grafts.

### Schnyder Corneal Dystrophy

Schnyder corneal dystrophy is an autosomal dominant condition caused by mutations in the UBIAD1 gene, characterized by cholesterol and phospholipid deposition in the corneal stroma. The slit lamp findings evolve characteristically with age: before age 23, central crystalline deposits are present in about 50% of patients; between ages 23 and 38, an arcus lipoides develops; and after age 38, progressive midperipheral and central haze becomes evident. A fasting lipid panel should be checked in all patients, as systemic dyslipidemia is commonly associated. PTK or keratoplasty may be needed for visually significant disease.

## Endothelial Dystrophies

### Fuchs Endothelial Corneal Dystrophy

Fuchs dystrophy is the most common endothelial dystrophy, with a female predominance of approximately 3-4:1. It is inherited in an autosomal dominant pattern with variable penetrance; the most commonly implicated gene is TCF4, harboring a trinucleotide repeat expansion (CTG18.1), while COL8A2 mutations are responsible for an early-onset variant. The fundamental pathophysiology involves progressive loss of endothelial cells combined with the formation of excrescences on Descemet membrane called guttae. As endothelial cell density falls below a critical threshold, the endothelial pump fails and stromal and epithelial edema develop.

On slit lamp examination, cornea guttae produce a characteristic beaten-metal appearance of the endothelium, most prominent centrally. With progression, Descemet membrane thickens, stromal edema develops (reflected in increased pachymetry readings), and eventually epithelial edema appears with microcystic bullae. In end-stage disease, subepithelial fibrosis develops. A hallmark symptom is blurred vision that is worse upon waking in the morning -- because overnight lid closure reduces evaporation, increasing corneal edema -- and gradually improves through the day. Patients also report glare, haloes, fluctuating vision, and pain from ruptured epithelial bullae.

The Krachmer grading system stages the disease from Grade 1 (0-12 scattered central guttae) through Grade 5 (greater than 5 mm of confluent guttae with stromal and epithelial edema). Specular microscopy reveals the guttae as dark bodies amid endothelial cells with reduced density, polymegathism, and pleomorphism.

Conservative treatment includes hypertonic saline drops (NaCl 5%) and warm, dry air directed at the eye (such as a hair dryer held at arm's length) to promote evaporative dehydration. When surgical intervention is needed, Descemet membrane endothelial keratoplasty (DMEK) is the preferred procedure, offering the fastest visual recovery and lowest rejection rate. DSAEK is a technically easier alternative with slightly slower visual recovery. PK is now reserved for cases with combined stromal scarring or failed prior grafts. An important surgical consideration arises when cataract surgery is needed in a Fuchs patient: the surgeon must assess endothelial reserve and decide between a triple procedure (phacoemulsification + IOL + DSAEK/DMEK) and sequential staged surgery.

### Posterior Polymorphous Corneal Dystrophy (PPCD)

PPCD is an autosomal dominant dystrophy associated with mutations in the OVOL2, ZEB1, or GRHL2 genes. The defining feature is that the endothelial cells take on epithelial-like characteristics, a process termed metaplasia. Slit lamp examination may reveal vesicular lesions, band-like lesions, or diffuse haze at the level of Descemet membrane. Most patients are asymptomatic, but severe cases can develop corneal edema. Associated findings include iridocorneal adhesions and glaucoma. PPCD must be distinguished from iridocorneal endothelial (ICE) syndrome, which is unilateral and non-hereditary, whereas PPCD is bilateral and inherited.

### Congenital Hereditary Endothelial Dystrophy (CHED)

CHED is an autosomal recessive dystrophy caused by mutations in the SLC4A11 gene. It presents at birth or within the first few years of life with bilateral diffuse corneal edema, producing cloudy corneas. Unlike Fuchs dystrophy, no guttae are present. Nystagmus may develop secondary to visual deprivation. Early surgical intervention with PK or endothelial keratoplasty (DSAEK/DMEK) is critical to prevent amblyopia.

## Classic Stromal Dystrophies Comparison

| Feature | Lattice (Type 1) | Granular (Type 1) | Macular | Avellino (Granular Type 2) |
|---------|-------------------|--------------------|---------|-----------------------------|
| Inheritance | AD | AD | AR | AD |
| Gene/Mutation | TGFBI R124C | TGFBI R555W | CHST6 | TGFBI R124H |
| Deposit | Amyloid | Hyaline | GAG (keratan sulfate) | Amyloid + Hyaline |
| Slit lamp | Refractile lattice lines | Breadcrumb/snowflake opacities | Gray-white, diffuse to limbus | Combined lattice + granular |
| Intervening stroma | Clear | Clear | Hazy | Clear |
| Corneal thickness | Normal | Normal | Thin | Normal |
| Peripheral involvement | Spares periphery | Spares periphery | Extends to limbus | Spares periphery |
| Stain | Congo red (apple-green birefringence) | Masson trichrome (red) | Alcian blue | Congo red + Masson trichrome |
| Recurrent erosions | Common | Less common | Less common | Variable |
| Graft recurrence | High (3-5 yr) | Moderate | Lowest | Moderate |
| LASIK | Caution | Caution | Caution | Absolutely contraindicated |

## The TGFBI Gene -- A Unifying Concept

One of the most elegant concepts in corneal dystrophy genetics is the role of the TGFBI gene on chromosome 5q31, which encodes transforming growth factor beta-induced protein (also known as keratoepithelin or BIGH3). Different point mutations in this single gene produce clinically distinct dystrophies: R124C causes lattice type 1 (amyloid deposits), R124H causes Avellino/granular type 2 (combined amyloid and hyaline), R124L causes Reis-Bucklers (hyaline-like deposits), R555W causes granular type 1 (hyaline deposits), and R555Q causes Thiel-Behnke (curly fibers). Homozygous mutations invariably produce more severe and earlier-onset disease than heterozygous states. Genetic testing for TGFBI mutations is clinically available and particularly valuable before refractive surgery in populations where these dystrophies are prevalent.

<image>Comparative slit lamp montage of the four classic stromal corneal dystrophies. Panel A: Lattice dystrophy showing refractile, branching lattice lines in the anterior stroma on retro-illumination with a clear peripheral cornea. Panel B: Granular dystrophy type 1 showing discrete, white, breadcrumb-shaped hyaline deposits in the central stroma with clear intervening spaces. Panel C: Macular dystrophy showing gray-white opacities with indistinct borders extending to the limbus and diffuse stromal haze. Panel D: Avellino (granular type 2) dystrophy showing both granular white deposits and fine lattice lines in the same cornea. Label each panel clearly.</image>

<image>Histopathologic staining comparison of stromal corneal dystrophies. Three side-by-side panels at high magnification: (1) Lattice dystrophy stained with Congo red showing amyloid deposits with apple-green birefringence under polarized light; (2) Granular dystrophy stained with Masson trichrome showing bright red hyaline deposits; (3) Macular dystrophy stained with Alcian blue showing blue-staining glycosaminoglycan deposits in the stroma and within keratocytes. Include labels for the stain used and the deposited material in each panel.</image>

<image>Clinical progression of Fuchs endothelial corneal dystrophy across five stages. From left to right: Stage 1 — scattered central guttae visible as dark spots on specular reflection with otherwise clear cornea; Stage 2 — confluent central guttae creating a beaten-metal endothelial reflex; Stage 3 — stromal edema with increased corneal thickness and Descemet folds; Stage 4 — epithelial edema with microcystic bullae on the corneal surface; Stage 5 — subepithelial fibrosis with pannus and permanent scarring. Include a pachymetry reading and specular microscopy inset for the early stages.</image>

<image>TGFBI gene mutation map diagram. A schematic of the TGFBI gene on chromosome 5q31 with the four key mutation hotspots at codons R124 and R555 highlighted. Branching arrows from each mutation point to the resulting dystrophy: R124C leads to Lattice type 1 (amyloid), R124H leads to Avellino/Granular type 2 (amyloid + hyaline), R124L leads to Reis-Bucklers (hyaline-like), R555W leads to Granular type 1 (hyaline), R555Q leads to Thiel-Behnke (curly fibers). For each dystrophy, include a small representative slit lamp image and the characteristic histologic deposit type.</image>

## Key Clinical Pearls

TGFBI gene mutations account for the majority of anterior and stromal corneal dystrophies, and knowing the mutation-to-phenotype map is essential for board examinations. LASIK is absolutely contraindicated in Avellino (granular type 2) dystrophy because flap interface deposits cause severe vision loss. Macular dystrophy is the "odd one out" among the classic stromal triad: it is autosomal recessive, produces a thinner cornea, extends to the limbus, and causes the earliest visual impairment. The classic history of Fuchs dystrophy is blurred vision that is worse in the morning due to overnight corneal hydration. The endothelium should always be evaluated with specular microscopy or pachymetry before cataract surgery in any patient with visible guttae. EBMD is the most common cause of recurrent corneal erosions and must be identified before refractive surgery. Among the stromal dystrophies, lattice has the highest graft recurrence rate and macular has the lowest. PPCD must be distinguished from ICE syndrome: PPCD is bilateral, hereditary, and usually asymptomatic, while ICE is unilateral, acquired, and progressive.

## References

- Weiss JS, et al. IC3D Classification of Corneal Dystrophies — Edition 2. Cornea. 2015;34(2):117-159.
- Klintworth GK. Corneal dystrophies. Orphanet J Rare Dis. 2009;4:7.
- Munier FL, et al. TGFBI corneal dystrophies: genotype-phenotype correlations. Ophthalmology. 2002;109(12):2230-2237.
- Patel SV. Graft survival and endothelial outcomes in the new era of endothelial keratoplasty. Exp Eye Res. 2012;95(1):40-47.
- AAO BCSC Section 8: External Disease and Cornea. 2023-2024.